PROJECT
ABSTRACT
Problem
Access
to modern clinical and laboratory genetic services is the problem of
patients and families in AR, IA, KS, MO, ND, NE, OK, and SD, owing to the
low number of geneticists and a maldistribution of them. Problems of the
region’s geneticists are the low level of external funding of medical
genetics services and research, the slow pace at expanding newborn
screening, and the lack of effective communication and networking in the
region to address gaps in services and to facilitate quality genetic
services.
Goals and Objectives
The
Heartland Genetics and Newborn Screening Collaborative will create a network
of clinical, laboratory, and public health genetics services that will
enhance existing services, including newborn screening, and increase the
public’s access to, and address the maldistribution of, clinical and
laboratory genetic services. The project’s objectives are: 1) establish
Advisory Council of key stakeholders to prioritize and guide regional
infrastructure, communication, and educational needs; 2) develop the
Heartland Regional Genetics Plan by the end of Year 1; and 3) fund regional
pilot projects that address identified regional priorities.
Methodology
1)
Establish a Steering Committee to nominate the Advisory Council and set the
agenda for the first Advisory Council meeting; 2) conduct an Advisory
Council meeting in February 2005, to prioritize the region’s services and
educational needs; 3) develop the Heartland Regional Genetics Plan; 4)
establish working groups to address the education and communication needs in
the region; and 5) fund Pilot Projects that meet state and regional needs.
Coordination
Efforts will be coordinated through the Regional Center in Oklahoma and
guided by the Advisory Council. The Regional Center will be the primary link
between HRSA, the National Coordinating Center, and the regional Advisory
Council. Inter-regional efforts will be facilitated by the National Center
and by asking a representative from a neighboring region to attend Advisory
Council meetings.
Evaluation
Quantitative and qualitative evaluation tools will be used to measure
tangible products such as the Heartland Regional Genetics Plan, a directory,
website, and meeting minutes; real progress versus work plan; description of
the type and number of shared resources and collaborative relationships pre-
and post-intervention; impact of pilot projects; and impact on access and
education by comparing responses of key stakeholders and target populations
pre- and post-intervention.
Annotation
Improved access to quality clinical and laboratory genetics services
requires a coordinated network of stakeholders; communication
infrastructure; comprehensive strategic plan; and specific, measurable
efforts that address limited resources, educational needs, and service
delivery.